About Us

Albert Einstein College of Medicine, a part of Montefiore is

a premier, research-intensive medical school dedicated to

innovative biomedical investigation and to the
development of master bioethics and compassionate
physicians and scientists. Inspired by the words of our
namesake, we have from our inception welcomed
students, faculty and staff from diverse backgrounds who
strive to enhance human health in the community and
beyond. This is an attribute in which Albert Einstein took
great pride when consenting to the use of his name in
conjunction with the medical school.
At the core of the Einstein-Montefiore mission is the
pursuit of social justice in meeting the healthcare needs of
all individuals, including those from underserved
communities.

Education
Einsteins M.D. program prepares tomorrows physicians to

excel in both the science and the art of medicine by

combining the pursuit of scientific excellence with
compassionate and humanistic care and the social mission to
improve human health through engagement in our local,
national, and global communities. Our Graduate Programs in
the Biomedical Sciences train some of todays brightest
students to become the next generation of leading scientific
researchers, while our Medical Scientist Training Program
(resulting in both M.D. and Ph.D. degrees) embraces a
comprehensive "bench to bedside" philosophy to nurture the
development of well-rounded physician-scientists. In all, the
College of Medicine offers six graduate degree programs.

Research
Boosting Liver DetoxificationThe liver is essential for removing

molecules such as drugs and toxins from the bloodstreama job

done by hepatocytes, cells that comprise most of the livers mass
and remove these compounds from the blood using specialized
transporter proteins. Allan Wolkoff, M.D., has received a $2.3
million, five-year renewal grant from the NIH to continue his
research on improving the livers detoxification ability. In a healthy
liver, these transporter proteins are in a balanced state as they
travel between the cell surface of hepatocytes and vesicles within
the cells. But disease can disrupt this equilibrium, causing so few
transporters at the cell surface that toxic compounds can
accumulate in the blood. Dr. Wolk off is studying the molecular
mechanisms that govern transporter trafficking and the cell-surface
expression of transporter proteins. His research may lead to
strategies for improving the liver-mediated clearance of chemicals
from the circulation.

Health
Editors' Note: February 29 marks the ninth
annual Rare Disease Day, a worldwide event
devoted to raising awareness of more than 6,500
rare diseases, of which less than 5 percent have
any available treatment. In September 2015,
Montefiore assumed operational and financial
control of Einstein. Together they advance clinical
and translational research to accelerate the pace
at which new discoveries become the treatments
and therapies that benefit patients.

Contact Us:-

http://www.einstein.yu.edu/